Prof. Peter Valent hosted an international collaboration meeting at the Medical University Vienna
Within the SFB47 a closed collaboration meeting was held on June 7-8. Members of the consortium met with international collaborators from France to explore the perspectives to target STAT5 pharmacologically. LBI-CR researchers participated in this meeting actively and contributed with their extensive expertise in modifying STAT activity in vivo and in vitro.